SENS PubMed Publication Search
Nicotinamide Mononucleotide Ameliorates Cellular Senescence and Inflammation Caused by Sodium Iodate in RPE
Oxid Med Cell Longev. 2022 Jul 18;2022:5961123. doi: 10.1155/2022/5961123.
Chengda Ren 1, Chengyu Hu 1, Yan Wu 1, Tingting Li 1, Aiqi Zou 1, Donghui Yu 1, Tianyi Shen 1, Wenting Cai 1, Jing Yu 1
Abstract:
...In this study, RPE cell senescence was confirmed to be potentially induced by NaIO3. The results showed that the number of senescence-associated-β-galactosidase (SA-β-gal-)-positive cells and the protein levels of p16 and p21 increased after NaIO3 treatment. Additionally, the senescent RPE cells underwent oxidative stress and NAD+ depletion. Furthermore, significant DNA damage and mitochondrial dysfunction were also detected in senescent RPE cells. The antioxidant N-acetylcysteine (NAC) could alleviate cellular senescence only by a minimal degree, whereas supplementation with nicotinamide mononucleotide (NMN) strongly ameliorated RPE senescence through the alleviation of DNA damage and the maintenance of mitochondrial function. The protective effects of NMN were demonstrated to rely on undisturbed Sirt1 signaling. Moreover, both the expression of senescence markers of RPE and subretinal inflammatory cell infiltration were decreased by NMN treatment in vivo. Our results indicate that RPE senescence induced by NaIO3 acquired several key features of AMD. More importantly, NMN may potentially be used to treat RPE senescence and senescence-associated pre-AMD changes by restoring the NAD+ levels in cells and tissues.
PMID: 35898618
Free Full-Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313989/
Tags: cell culture, NMN, Reverses senescence